Published in Jpn J Clin Oncol on November 12, 2008
Prognostic significance of pathological complete response following neoadjuvant chemotherapy for operable breast cancer. Oncol Lett (2014) 0.86
Gamma knife radiosurgery for brain metastases from breast cancer. J Korean Neurosurg Soc (2013) 0.81
Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys (2005) 4.14
Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the international atomic energy agency. Int J Radiat Oncol Biol Phys (2005) 2.19
Clinicopathological features of tumors as predictors of the efficacy of primary neoadjuvant chemotherapy for operable breast cancer. World J Surg (2009) 2.02
Expression of insulin-like growth factor 1 receptor in primary breast cancer: immunohistochemical analysis. Hum Pathol (2004) 1.77
The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races. Breast (2007) 1.64
Weekly paclitaxel and carboplatin against advanced transitional cell cancer after failure of a platinum-based regimen. Eur Urol (2007) 1.56
Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer. Breast Cancer Res Treat (2011) 1.55
Optimized local infarct restraint improves left ventricular function and limits remodeling. Ann Thorac Surg (2012) 1.55
The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways. Nat Cell Biol (2009) 1.51
High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients. Clin Cancer Res (2002) 1.49
Acceleration of chromosomal instability of BRCA1-associated hereditary breast cancers by p53 abnormality. Breast J (2002) 1.48
Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys (2002) 1.48
Health-related quality of life after radical retropubic prostatectomy and permanent prostate brachytherapy: a 3-year follow-up study. Int J Urol (2011) 1.46
Multi-institutional study of radiation therapy for isolated para-aortic lymph node recurrence in uterine cervical carcinoma: 84 subjects of a population of more than 5,000. Int J Radiat Oncol Biol Phys (2006) 1.45
Gamma Knife surgery for brain metastases from colorectal cancer. Clinical article. J Neurosurg (2010) 1.43
Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in ApcMin/+ mice with natural ligands. Proc Natl Acad Sci U S A (2009) 1.40
Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer. Radiat Med (2008) 1.36
Prediction of prognosis of estrogen receptor-positive breast cancer with combination of selected estrogen-regulated genes. Cancer Sci (2004) 1.31
Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors. J Neurooncol (2008) 1.28
Gene expression profiling of ATP-binding cassette (ABC) transporters as a predictor of the pathologic response to neoadjuvant chemotherapy in breast cancer patients. Breast Cancer Res Treat (2006) 1.25
Phase II study of preoperative sequential FEC and docetaxel predicts of pathological response and disease free survival. Breast Cancer Res Treat (2007) 1.25
Evaluation of lung injury after three-dimensional conformal stereotactic radiation therapy for solitary lung tumors: CT appearance. Radiology (2003) 1.20
A survey of radiation-induced bronchiolitis obliterans organizing pneumonia syndrome after breast-conserving therapy in Japan. Int J Radiat Oncol Biol Phys (2007) 1.19
Reduction of ischemia/reperfusion injury with bendavia, a mitochondria-targeting cytoprotective Peptide. J Am Heart Assoc (2012) 1.14
Prediction of response to docetaxel by quantitative analysis of class I and III beta-tubulin isotype mRNA expression in human breast cancers. Clin Cancer Res (2003) 1.12
Efficacy of everolimus, a novel mTOR inhibitor, against basal-like triple-negative breast cancer cells. Cancer Sci (2012) 1.10
In vivo chronic myocardial infarction characterization by spin locked cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2012) 1.09
Influence of injectable hyaluronic acid hydrogel degradation behavior on infarction-induced ventricular remodeling. Biomacromolecules (2011) 1.08
Docetaxel followed by fluorouracil/epirubicin/cyclophosphamide as neoadjuvant chemotherapy for patients with primary breast cancer. Jpn J Clin Oncol (2011) 1.07
Differentiation of tumor recurrence from radiation-induced pulmonary fibrosis after stereotactic ablative radiotherapy for lung cancer: characterization of 18F-FDG PET/CT findings. Ann Nucl Med (2013) 1.07
Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2). Int J Radiat Oncol Biol Phys (2011) 1.07
Immunohistochemical expression of PTEN and phosphorylated Akt are not correlated with clinical outcome in breast cancer patients treated with trastuzumab-containing neo-adjuvant chemotherapy. Med Oncol (2008) 1.05
Issues in the assessment of the pathologic effect of primary systemic therapy for breast cancer. Breast Cancer (2006) 1.05
Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group. Breast Cancer Res Treat (2009) 1.05
Patterns of radiotherapy practice for patients with cervical cancer (1999-2001): patterns of care study in Japan. Int J Radiat Oncol Biol Phys (2008) 1.04
Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer. Int J Clin Oncol (2009) 1.03
Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 ring study. Cancer Sci (2013) 1.03
Stat3 up-regulates expression of nicotinamide N-methyltransferase in human cancer cells. J Cancer Res Clin Oncol (2007) 1.02
Local hyperthermia combined with external irradiation for regional recurrent breast carcinoma. Int J Clin Oncol (2004) 1.02
Posterior leaflet augmentation improves leaflet tethering in repair of ischemic mitral regurgitation. Eur J Cardiothorac Surg (2011) 1.02
Multi-institutional analysis of early squamous cell carcinoma of the hypopharynx treated with radical radiotherapy. Int J Radiat Oncol Biol Phys (2006) 1.02
Patterns of radiotherapy practice for patients with cervical cancer in Japan, 2003-2005: changing trends in the pattern of care process. Int J Radiat Oncol Biol Phys (2012) 1.00
Sentinel node biopsy for breast cancer: technical aspects and controversies. Breast Cancer (2007) 1.00
IL12RB2 and ABCA1 genes are associated with susceptibility to radiation dermatitis. Clin Cancer Res (2008) 0.99
Immunohistochemical evaluation for hormone receptors in breast cancer: a practically useful evaluation system and handling protocol. Breast Cancer (2006) 0.99
Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society. Breast Cancer (2009) 0.99
Mutational analysis of BARD1 in familial breast cancer patients in Japan. Cancer Lett (2003) 0.99
Significance of serum tumor markers in monitoring advanced breast cancer patients treated with systemic therapy: a prospective study. Breast Cancer (2004) 0.98
A multi-institutional retrospective analysis of external radiotherapy for mucosal melanoma of the head and neck in Northern Japan. Int J Radiat Oncol Biol Phys (2004) 0.98
Radiation pneumonitis caused by a migrated brachytherapy seed lodged in the lung. Jpn J Clin Oncol (2008) 0.97
Comparison of breast cancer detection by diffusion-weighted magnetic resonance imaging and mammography. Radiat Med (2007) 0.96
Mutational analysis of the class I beta-tubulin gene in human breast cancer. Int J Cancer (2002) 0.96
Bilateral breast-conserving therapy for bilateral breast cancer: results and consideration of radiation technique. Breast Cancer (2005) 0.95
Loss of BRCA1 expression may predict shorter time-to-progression in metastatic breast cancer patients treated with taxanes. Anticancer Res (2006) 0.95
Clinical outcomes of carbon ion radiotherapy for locally advanced adenocarcinoma of the uterine cervix in phase 1/2 clinical trial (protocol 9704). Cancer (2014) 0.95
The notorious "drug lag" for oncology drugs in Japan. Invest New Drugs (2011) 0.95
A multi-institutional phase II trial of paclitaxel and carboplatin in the treatment of advanced or recurrent cervical cancer. Gynecol Oncol (2012) 0.94
Cisplatin induces production of reactive oxygen species via NADPH oxidase activation in human prostate cancer cells. Free Radic Res (2011) 0.94
Efficacy of taxane regimens in patients with metastatic angiosarcoma. Eur J Dermatol (2011) 0.94
An alternative medicine, Agaricus blazei, may have induced severe hepatic dysfunction in cancer patients. Jpn J Clin Oncol (2006) 0.93
Local control of metastatic lung tumors treated with SBRT of 48 Gy in four fractions: in comparison with primary lung cancer. Jpn J Clin Oncol (2009) 0.93
Multicenter phase II trial assessing effectiveness of imatinib mesylate on relapsed or refractory KIT-positive or PDGFR-positive sarcoma. J Orthop Sci (2010) 0.93
Japanese structure survey of radiation oncology in 2007 based on institutional stratification of patterns of care study. Int J Radiat Oncol Biol Phys (2010) 0.93
Impact of boost irradiation on pelvic lymph node control in patients with cervical cancer. J Radiat Res (2013) 0.93
Factors that affect the duration of the interval between the completion of palliative chemotherapy and death. Oncologist (2009) 0.92
Insufficiency fractures after pelvic radiation therapy for uterine cervical cancer: an analysis of subjects in a prospective multi-institutional trial, and cooperative study of the Japan Radiation Oncology Group (JAROG) and Japanese Radiation Oncology Study Group (JROSG). Int J Radiat Oncol Biol Phys (2012) 0.92
HER2 testing on core needle biopsy specimens from primary breast cancers: interobserver reproducibility and concordance with surgically resected specimens. BMC Cancer (2010) 0.92
Diagnosis of complete response to neoadjuvant chemotherapy using diagnostic imaging in primary breast cancer patients. Breast J (2005) 0.92
Development of severe complications caused by stent placement followed by definitive radiation therapy for T4 esophageal cancer. Int J Clin Oncol (2003) 0.91
Posterior leaflet augmentation in ischemic mitral regurgitation increases leaflet coaptation and mobility. Ann Thorac Surg (2012) 0.91
Current status of stereotactic body radiotherapy for lung cancer. Int J Clin Oncol (2007) 0.91
Current trends of sentinel lymph node biopsy for breast cancer--a surgeon's perspective. Breast Cancer (2007) 0.90
Current trends and controversies over pre-operative chemotherapy for women with operable breast cancer. Jpn J Clin Oncol (2007) 0.90
Sutureless mitral valve replacement: initial steps toward a percutaneous procedure. Ann Thorac Surg (2013) 0.90
Clinical outcomes of adult and childhood rhabdomyosarcoma treated with vincristine, d-actinomycin, and cyclophosphamide chemotherapy. J Cancer Res Clin Oncol (2012) 0.90
Gamma Knife surgery for metastatic brain tumors from primary breast cancer: treatment indication based on number of tumors and breast cancer phenotype. J Neurosurg (2010) 0.90
Concurrent chemoradiotherapy for esophageal cancer: comparison between intermittent standard-dose cisplatin with 5-fluorouracil and daily low-dose cisplatin with continuous infusion of 5-fluorouracil. Int J Clin Oncol (2004) 0.89
Are there high-risk subgroups for isolated locoregional failure in patients who had T1/2 breast cancer with one to three positive lymph nodes and received mastectomy without radiotherapy? Breast Cancer (2012) 0.89
A randomized phase II study of cisplatin/5-FU concurrent chemoradiotherapy for esophageal cancer: Short-term infusion versus protracted infusion chemotherapy (KROSG0101/JROSG021). Radiother Oncol (2009) 0.89
Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer. Cancer Res (2005) 0.89
Preparation of magnetic iron oxide nanoparticles for hyperthermia of cancer in a FeCl₂-NaNO₃-NaOH aqueous system. J Biomater Appl (2010) 0.89
Contractile mitral annular forces are reduced with ischemic mitral regurgitation. J Thorac Cardiovasc Surg (2012) 0.89
[Pulmonary tumor thrombotic microangiopathy responding to chemotherapy]. Nihon Kokyuki Gakkai Zasshi (2011) 0.88
A new method for protection from shower embolism during TEVAR on a shaggy aorta. Gen Thorac Cardiovasc Surg (2013) 0.88
Melody valve implantation into the branch pulmonary arteries for treatment of pulmonary insufficiency in an ovine model of right ventricular outflow tract dysfunction following tetralogy of Fallot repair. Circ Cardiovasc Interv (2011) 0.88
Volume-based parameters of 18F-fluorodeoxyglucose positron emission tomography/computed tomography improve disease recurrence prediction in postmastectomy breast cancer patients with 1 to 3 positive axillary lymph nodes. Int J Radiat Oncol Biol Phys (2013) 0.88
Comparison of evaluations for hormone receptors in breast carcinoma using two manual and three automated immunohistochemical assays. Am J Clin Pathol (2007) 0.88
Microvesicles released from hormone-refractory prostate cancer cells facilitate mouse pre-osteoblast differentiation. J Mol Histol (2012) 0.88
Nipple adenoma found in a mastectomy specimen: report of a case with special regard to the proliferation pattern. Breast Cancer (2007) 0.88
Targeted deletion of the C-terminus of the mouse adenomatous polyposis coli tumor suppressor results in neurologic phenotypes related to schizophrenia. Mol Brain (2014) 0.87
Health-related quality of life after bladder preservation therapy for muscle invasive bladder cancer. Int J Urol (2008) 0.87
What causes discrepancies in HER2 testing for breast cancer? A Japanese ring study in conjunction with the global standard. Am J Clin Pathol (2008) 0.87
Phase I and pharmacokinetic study of trabectedin, a DNA minor groove binder, administered as a 24-h continuous infusion in Japanese patients with soft tissue sarcoma. Invest New Drugs (2014) 0.87
Radiotherapy for patients with localized hormone-refractory prostate cancer: results of the Patterns of Care Study in Japan. BJU Int (2009) 0.87